The Effectiveness of Video Education How to Use Diskus® DryPowder inhaler on Out-Patients Copd In Mojokerto, Indonesia

S. Mahfouz, Z. Ikawati, D. Wahyono
{"title":"The Effectiveness of Video Education How to Use Diskus® DryPowder inhaler on Out-Patients Copd In Mojokerto, Indonesia","authors":"S. Mahfouz, Z. Ikawati, D. Wahyono","doi":"10.25258/ijpcr.v9i3.8325","DOIUrl":null,"url":null,"abstract":"COPD therapy aims to prevent and overcome acute exacerbation on COPD which could be fatal and even lead to death. Thus, it must be prevented with optimum medication during stable condition. Bronchodilator in the form of inhalation are preferred in COPD medication because systemic bronchodilator has many side effects compared to that of topical bronchodilator (inhalation). DPI (dry-powder inhaler) has been developed and introduced to the market since 1967 as a solution or choice concerning MDI (metered-dose inhaler) setbacks where patients felt difficult in coordinating hands and lungs. Evidences suggested that multi-unit dose DPI such as Diskus® offered most reliable and consistent performance and it is preferred by patients. The improper using of inhaler is one of the main causes holding up asthma control since it can affect patients dosage intake which is not optimal. This research aimed to know the efficacy of Diskus® preparation usage education given to COPD patients. Method used in this research was one study group pre-test dan post test. The number of respondents involved in this research was 55 respondents. The result of t-test suggested that t-count is fewer than p-value (0.05) suggesting that there was difference between pre and post test score as a result of oral or motor evaluation. It is then concluded that Diskus® usage education affected the patients in the improvement of inhaler usage accuracy based on oral and motor evaluation. This research only reviewed COPD patients skill in using Diskus®, thus it is required to conduct further research to dig the understanding in the usage of Diskus® like drug indications, interval, how to notice side effects and how to overcome them. Also, this research only reviewed knowledge increase, but yet described outcome improvement from the using of COPD therapy itself.","PeriodicalId":19889,"journal":{"name":"Pharmaceutical and Clinical Research","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2017-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical and Clinical Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.25258/ijpcr.v9i3.8325","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

COPD therapy aims to prevent and overcome acute exacerbation on COPD which could be fatal and even lead to death. Thus, it must be prevented with optimum medication during stable condition. Bronchodilator in the form of inhalation are preferred in COPD medication because systemic bronchodilator has many side effects compared to that of topical bronchodilator (inhalation). DPI (dry-powder inhaler) has been developed and introduced to the market since 1967 as a solution or choice concerning MDI (metered-dose inhaler) setbacks where patients felt difficult in coordinating hands and lungs. Evidences suggested that multi-unit dose DPI such as Diskus® offered most reliable and consistent performance and it is preferred by patients. The improper using of inhaler is one of the main causes holding up asthma control since it can affect patients dosage intake which is not optimal. This research aimed to know the efficacy of Diskus® preparation usage education given to COPD patients. Method used in this research was one study group pre-test dan post test. The number of respondents involved in this research was 55 respondents. The result of t-test suggested that t-count is fewer than p-value (0.05) suggesting that there was difference between pre and post test score as a result of oral or motor evaluation. It is then concluded that Diskus® usage education affected the patients in the improvement of inhaler usage accuracy based on oral and motor evaluation. This research only reviewed COPD patients skill in using Diskus®, thus it is required to conduct further research to dig the understanding in the usage of Diskus® like drug indications, interval, how to notice side effects and how to overcome them. Also, this research only reviewed knowledge increase, but yet described outcome improvement from the using of COPD therapy itself.
视频教育如何使用Diskus®干粉吸入器治疗印尼Mojokerto门诊Copd患者的效果
慢性阻塞性肺病治疗的目的是预防和克服慢性阻塞性肺病急性加重,这可能是致命的,甚至导致死亡。因此,必须在稳定状态下用最佳药物预防。由于全身支气管扩张剂与局部支气管扩张剂(吸入性)相比有许多副作用,因此吸入形式的支气管扩张剂在COPD药物治疗中是首选。自1967年以来,DPI(干粉吸入器)已经开发并推向市场,作为MDI(计量吸入器)挫折的解决方案或选择,患者感到手和肺难以协调。有证据表明,多单位剂量DPI如Diskus®提供了最可靠和一致的性能,是患者的首选。吸入器的使用不当是阻碍哮喘控制的主要原因之一,因为吸入器的使用不当会影响患者的剂量摄入。本研究旨在了解Diskus®制剂使用教育对COPD患者的疗效。本研究采用一组前测和后测的方法。参与这项研究的受访者人数为55人。t检验结果显示,t计数小于p值(0.05),表明口腔或运动评估的测试前后评分存在差异。通过口腔和运动评估,得出Diskus®使用教育对患者吸入器使用准确性的提高有影响。本研究仅回顾了COPD患者对Diskus®的使用技巧,需要进一步的研究来了解Diskus®的使用情况,如药物适应症、间隔、如何注意副作用以及如何克服副作用等。此外,本研究仅回顾了知识的增加,但尚未描述使用COPD治疗本身的结果改善。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
4693
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信